 |
|
Discontinuation of Nonsteroidal Anti-inflammatory Drug Therapy and Risk of Acute Myocardial Infarction
Lorenz M. Fischer, MSc;
Raymond G. Schlienger, PhD, MPH;
Christian M. Matter, MD;
Hershel Jick, MD;
Christoph R. Meier, PhD, MSc
Arch Intern Med. 2004;164:2472-2476.
Background Systemic inflammation has been shown to be associated with an increased risk of acute myocardial infarction (AMI). However, the effect of the use of nonsteroidal anti-inflammatory drugs (NSAIDs) on the risk of AMI has not yet been well defined. We therefore studied the risk of AMI during NSAID exposure and after the cessation of NSAID therapy.
Methods We conducted a large case-control analysis on the British General Practice Research Database. The study included 8688 cases with a first-time AMI between 1995 and 2001 and 33 923 controls, matched to cases on age, sex, calendar time, and general practice attended.
Results After adjusting for hypertension, hyperlipidemia, diabetes mellitus, ischemic heart disease, rheumatoid arthritis, systemic lupus erythematosus, acute chest infection, body mass index, smoking, and aspirin use, the risk of AMI was 1.52 (95% confidence interval [CI], 1.33-1.74) for subjects who stopped taking NSAIDs 1 to 29 days prior to the index date, compared with nonusers. The risk was highest in subjects with rheumatoid arthritis or systemic lupus erythematosus (adjusted OR, 3.68 [95% CI, 2.36-5.74]) and for subjects who discontinued therapy with NSAIDs after previous long-term use (adjusted OR, 2.60 [95% CI, 1.84-3.68]). Current and past NSAID use (discontinued therapy  60 days prior to the index date) were not associated with an increased risk of AMI (adjusted OR, 1.07 [95% CI, 0.96-1.19] and 1.05 [95% CI, 0.99-1.12], respectively).
Conclusion Our findings suggest that the risk of AMI is increased during several weeks after the cessation of NSAID therapy.
Author Affiliations: Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland (Mr Fischer and Drs Schlienger and Meier); Cardiovascular Research, Institute of Physiology, University of Zurich, and Division of Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland (Dr Matter); and Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Mass (Drs Jick and Meier).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance
Gasparyan et al.
J Am Coll Cardiol 2008;51:1829-1843.
ABSTRACT
| FULL TEXT
Nonselective Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk: Are They Safe?
Waksman et al.
The Annals of Pharmacotherapy 2007;41:1163-1173.
ABSTRACT
| FULL TEXT
Human Antibody Against C Domain of Tenascin-C Visualizes Murine Atherosclerotic Plaques Ex Vivo
von Lukowicz et al.
JNM 2007;48:582-587.
ABSTRACT
| FULL TEXT
Cardiovascular Risk and Inhibition of Cyclooxygenase: A Systematic Review of the Observational Studies of Selective and Nonselective Inhibitors of Cyclooxygenase 2
McGettigan and Henry
JAMA 2006;296:1633-1644.
ABSTRACT
| FULL TEXT
Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
Gislason et al.
Circulation 2006;113:2906-2913.
ABSTRACT
| FULL TEXT
Understanding the NSAID related risk of vascular events.
Vonkeman et al.
BMJ 2006;332:895-898.
FULL TEXT
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Chan et al.
Circulation 2006;113:1578-1587.
ABSTRACT
| FULL TEXT
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy
Pijak
Arch Neurol 2006;63:300-301.
FULL TEXT
Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs
Bolten
Ann Rheum Dis 2006;65:7-13.
ABSTRACT
| FULL TEXT
Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs
Fosslien
Annals of Clinical & Laboratory Science 2005;35:347-385.
ABSTRACT
| FULL TEXT
Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target?
Bonvini et al.
Eur Heart J Suppl 2005;7:I27-I36.
ABSTRACT
| FULL TEXT
MI Risk Shortly After Stopping NSAIDs
Journal Watch Cardiology 2005;2005:5-5.
FULL TEXT
MI Risk Shortly After Stopping NSAIDs
JWatch General 2005;2005:6-6.
FULL TEXT
|
